155 related articles for article (PubMed ID: 34225755)
1. Long non-coding RNA ANRIL promotes homologous recombination-mediated DNA repair by maintaining ATR protein stability to enhance cancer resistance.
Liu L; Chen Y; Huang Y; Cao K; Liu T; Shen H; Cui J; Li B; Cai J; Gao F; Yang Y
Mol Cancer; 2021 Jul; 20(1):94. PubMed ID: 34225755
[No Abstract] [Full Text] [Related]
2. ZNF830 mediates cancer chemoresistance through promoting homologous-recombination repair.
Chen G; Chen J; Qiao Y; Shi Y; Liu W; Zeng Q; Xie H; Shi X; Sun Y; Liu X; Li T; Zhou L; Wan J; Xie T; Wang H; Wang F
Nucleic Acids Res; 2018 Feb; 46(3):1266-1279. PubMed ID: 29244158
[TBL] [Abstract][Full Text] [Related]
3. A long noncoding RNA sensitizes genotoxic treatment by attenuating ATM activation and homologous recombination repair in cancers.
Zhao K; Wang X; Xue X; Li L; Hu Y
PLoS Biol; 2020 Mar; 18(3):e3000666. PubMed ID: 32203529
[TBL] [Abstract][Full Text] [Related]
4. ATR-binding lncRNA ScaRNA2 promotes cancer resistance through facilitating efficient DNA end resection during homologous recombination repair.
Chen Y; Shen H; Liu T; Cao K; Wan Z; Du Z; Wang H; Yu Y; Ma S; Lu E; Zhang W; Cai J; Gao F; Yang Y
J Exp Clin Cancer Res; 2023 Sep; 42(1):256. PubMed ID: 37775817
[TBL] [Abstract][Full Text] [Related]
5. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer.
Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963582
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of lncRNA ANRIL inhibits the development of cisplatin resistance by upregulating miR‑98 in lung cancer cells.
Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Oncol Rep; 2020 Sep; 44(3):1025-1036. PubMed ID: 32705261
[TBL] [Abstract][Full Text] [Related]
7. The silencing of long non-coding RNA ANRIL suppresses invasion, and promotes apoptosis of retinoblastoma cells through the ATM-E2F1 signaling pathway.
Yang Y; Peng XW
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355646
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the ATR kinase enhances 5-FU sensitivity independently of nonhomologous end-joining and homologous recombination repair pathways.
Ito SS; Nakagawa Y; Matsubayashi M; Sakaguchi YM; Kobashigawa S; Matsui TK; Nanaura H; Nakanishi M; Kitayoshi F; Kikuchi S; Kajihara A; Tamaki S; Sugie K; Kashino G; Takahashi A; Hasegawa M; Mori E; Kirita T
J Biol Chem; 2020 Sep; 295(37):12946-12961. PubMed ID: 32675286
[TBL] [Abstract][Full Text] [Related]
9. Targeting MALAT1 induces DNA damage and sensitize non-small cell lung cancer cells to cisplatin by repressing BRCA1.
Huang J; Lin C; Dong H; Piao Z; Jin C; Han H; Jin D
Cancer Chemother Pharmacol; 2020 Nov; 86(5):663-672. PubMed ID: 33030583
[TBL] [Abstract][Full Text] [Related]
10. The long noncoding RNA ANRIL acts as an oncogene and contributes to paclitaxel resistance of lung adenocarcinoma A549 cells.
Xu R; Mao Y; Chen K; He W; Shi W; Han Y
Oncotarget; 2017 Jun; 8(24):39177-39184. PubMed ID: 28402932
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.
Jiang HG; Chen P; Su JY; Wu M; Qian H; Wang Y; Li J
J Cell Physiol; 2017 Dec; 232(12):3433-3443. PubMed ID: 28075014
[TBL] [Abstract][Full Text] [Related]
12. ATR suppresses endogenous DNA damage and allows completion of homologous recombination repair.
Brown AD; Sager BW; Gorthi A; Tonapi SS; Brown EJ; Bishop AJ
PLoS One; 2014; 9(3):e91222. PubMed ID: 24675793
[TBL] [Abstract][Full Text] [Related]
13. Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.
Doerr F; George J; Schmitt A; Beleggia F; Rehkämper T; Hermann S; Walter V; Weber JP; Thomas RK; Wittersheim M; Büttner R; Persigehl T; Reinhardt HC
Sci Rep; 2017 Nov; 7(1):15511. PubMed ID: 29138515
[TBL] [Abstract][Full Text] [Related]
14. ATR-mediated proteome remodeling is a major determinant of homologous recombination capacity in cancer cells.
Kim D; Liu Y; Oberly S; Freire R; Smolka MB
Nucleic Acids Res; 2018 Sep; 46(16):8311-8325. PubMed ID: 30010936
[TBL] [Abstract][Full Text] [Related]
15. Proficiency in homologous recombination repair is prerequisite for activation of G
Soni A; Mladenov E; Iliakis G
DNA Repair (Amst); 2021 May; 101():103076. PubMed ID: 33640756
[TBL] [Abstract][Full Text] [Related]
16. The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 signaling pathway in pancreatic cancer: An in vivo and in vitro study.
Chen S; Zhang JQ; Chen JZ; Chen HX; Qiu FN; Yan ML; Chen YL; Peng CH; Tian YF; Wang YD
Int J Biol Macromol; 2017 Sep; 102():718-728. PubMed ID: 28344092
[TBL] [Abstract][Full Text] [Related]
17. KU70 Inhibition Impairs Both Non-Homologous End Joining and Homologous Recombination DNA Damage Repair Through SHP-1 Induced Dephosphorylation of SIRT1 in T-Cell Acute Lymphoblastic Leukemia (T-ALL) [corrected].
Yu W; Li L; Wang G; Zhang W; Xu J; Liang A
Cell Physiol Biochem; 2018; 49(6):2111-2123. PubMed ID: 30273928
[TBL] [Abstract][Full Text] [Related]
18. A Genome-Wide Pooled shRNA Screen Identifies PPP2R2A as a Predictive Biomarker for the Response to ATR and CHK1 Inhibitors.
Qiu Z; Fa P; Liu T; Prasad CB; Ma S; Hong Z; Chan ER; Wang H; Li Z; He K; Wang QE; Williams TM; Yan C; Sizemore ST; Narla G; Zhang J
Cancer Res; 2020 Aug; 80(16):3305-3318. PubMed ID: 32522823
[TBL] [Abstract][Full Text] [Related]
19. The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of ATR-Chk1 Signaling.
Peng C; Chen Z; Wang S; Wang HW; Qiu W; Zhao L; Xu R; Luo H; Chen Y; Chen D; You Y; Liu N; Wang H
Cancer Res; 2016 Apr; 76(8):2340-53. PubMed ID: 26960975
[TBL] [Abstract][Full Text] [Related]
20. Coupling of Homologous Recombination and the Checkpoint by ATR.
Buisson R; Niraj J; Rodrigue A; Ho CK; Kreuzer J; Foo TK; Hardy EJ; Dellaire G; Haas W; Xia B; Masson JY; Zou L
Mol Cell; 2017 Jan; 65(2):336-346. PubMed ID: 28089683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
